We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).
- Authors
Ychou, M; Raoul, J-L; Douillard, J-Y; Gourgou-Bourgade, S; Bugat, R; Mineur, L; Viret, F; Becouarn, Y; Bouché, O; Gamelin, E; Ducreux, M; Conroy, T; Seitz, J-F; Bedenne, L; Kramar, A
- Abstract
This multicenter adjuvant phase III trial evaluated the addition of irinotecan to LV5FU2 in colon cancer patients at high risk of relapse.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Vol 20, Issue 4, p674
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdn680